
Cancer patients with less involvement in their treatment decisions are less likely to report excellent quality of care even if they prefer physician-controlled decisions, according to a study in JAMA Oncology.
Cancer patients with less involvement in their treatment decisions are less likely to report excellent quality of care even if they prefer physician-controlled decisions, according to a study in JAMA Oncology.
The study, published in the Journal of the National Cancer Institute, found that having a prior cancer diagnosis did not affect outcomes among the patients with advanced lung cancer, which means these patients should be allowed to take part in clinical trials of new lung cancer treatments.
Investigators at St. Jude Children's Research Hospital found that decades after undergoing cranial irradiation for childhood cancer, adult survivors remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Researchers at the University of Leicester and Leicester's Hospitals are evaluating a revolutionary device which detects lung cancer in early stages.
A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.
A new study debunks the common assumption that high medical costs are a result of patients demanding more tests and treatments. Researchers analyzed more than 5000 patient-clinician visits and found that cancer patients rarely push for medical interventions.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.